CONMED (CNMD) PT Raised to $45 at Piper Sandler

July 30, 2026 7:09 AM

Piper Sandler analyst Matt O'Brien raised the price target on CONMED (NYSE: CNMD) to $45.00 (from $39.00) while maintaining a Neutral rating.

No results found